Doctor Ji Jing has been appointed as Executive Director ABBISKO-B(02256)
Hoyo-B (02256) announced that Dr. Chen Zhui has resigned as an executive director of the company, effective March 3, 2025...
ABBISKO-B (02256) announced that Dr. Zui Chen has resigned as an executive director of the company, effective from March 3, 2025. Dr. Yuhong Ping, our current Chief Scientific Officer and executive director, will continue to lead our research and development work. Dr. Yaochang Xu, Dr. Yuhong Ping, and Dr. Zui Chen have entered into a termination agreement to terminate the joint action agreement, effective from March 3, 2025. Dr. Jing Ji has been appointed as an executive director of the company, effective from March 3, 2025.
Related Articles
HK Stock Market Move | Shenzhen Expressway Corporation (00548) rose over 4% in the final trading session. One-time impairments resulted in performance remaining basically flat year-on-year. Dividend payout ratio exceeded 50%.
UK regulatory agency announces final compensation plan for car loan mis-selling, Lloyds Banking Group plc Sponsored ADR (LYG.US) halts additional provisions.
New Stock News | It is rumored that Zhongji Innolight (300308.SZ) has secretly submitted documents to the Hong Kong Stock Exchange to raise at least $3 billion.
HK Stock Market Move | Shenzhen Expressway Corporation (00548) rose over 4% in the final trading session. One-time impairments resulted in performance remaining basically flat year-on-year. Dividend payout ratio exceeded 50%.
UK regulatory agency announces final compensation plan for car loan mis-selling, Lloyds Banking Group plc Sponsored ADR (LYG.US) halts additional provisions.
New Stock News | It is rumored that Zhongji Innolight (300308.SZ) has secretly submitted documents to the Hong Kong Stock Exchange to raise at least $3 billion.
